202 related articles for article (PubMed ID: 29245994)
1. Clinicopathological and prognostic significance of HMGA2 overexpression in gastric cancer: a meta-analysis.
Zhu J; Wang H; Xu S; Hao Y
Oncotarget; 2017 Nov; 8(59):100478-100489. PubMed ID: 29245994
[TBL] [Abstract][Full Text] [Related]
2. High mobility group protein A2 overexpression indicates poor prognosis for cancer patients: a meta-analysis.
Nie D; Zhang L; Guo Q; Mao X
Oncotarget; 2018 Jan; 9(1):1237-1247. PubMed ID: 29416690
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of high mobility group protein A2 (HMGA2) over-expression in cancer progression.
Binabaj MM; Soleimani A; Rahmani F; Avan A; Khazaei M; Fiuji H; Soleimanpour S; Ryzhikov M; Ferns GA; Bahrami A; Hassanian SM
Gene; 2019 Jul; 706():131-139. PubMed ID: 31055021
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of HMGA2 in Human Cancers: A Meta-Analysis Based on Literatures and TCGA Datasets.
Huang B; Yang J; Cheng Q; Xu P; Wang J; Zhang Z; Fan W; Wang P; Yu M
Front Physiol; 2018; 9():776. PubMed ID: 29997523
[No Abstract] [Full Text] [Related]
5. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
6. High mobility group A protein-2 as a tumor cancer diagnostic and prognostic marker: a systematic review and meta-analysis.
Thi-Hai Pham Y; Utuama O; Thomas CE; Park JA; La Vecchia C; Risch HA; Tran CT; Le TV; Boffetta P; Raskin L; Luu HN
Eur J Cancer Prev; 2020 Nov; 29(6):565-581. PubMed ID: 32898013
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis.
Yin S; Li Z; Huang J; Miao Z; Zhang J; Lu C; Xu H; Xu H
Onco Targets Ther; 2017; 10():319-327. PubMed ID: 28138255
[TBL] [Abstract][Full Text] [Related]
8. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition.
Lee J; Ha S; Jung CK; Lee HH
Int J Oncol; 2015; 46(6):2431-8. PubMed ID: 25845850
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of CD24 overexpression in patients with gastric cancer: a meta-analysis.
Wu JX; Zhao YY; Wu X; An HX
PLoS One; 2014; 9(12):e114746. PubMed ID: 25503963
[TBL] [Abstract][Full Text] [Related]
10. Clinical and prognostic significances of cancer stem cell markers in gastric cancer patients: a systematic review and meta-analysis.
Razmi M; Ghods R; Vafaei S; Sahlolbei M; Saeednejad Zanjani L; Madjd Z
Cancer Cell Int; 2021 Feb; 21(1):139. PubMed ID: 33639931
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of SOX9 expression in gastric cancer patients: A meta-analysis.
Wang Q; Chen H; Yang C; Liu Y; Li F; Zhang C
Medicine (Baltimore); 2022 Sep; 101(37):e30533. PubMed ID: 36123852
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of ADAM17 for Gastric Cancer Survival: A Meta-Analysis.
Ni P; Yu M; Zhang R; He M; Wang H; Chen S; Duan G
Medicina (Kaunas); 2020 Jun; 56(7):. PubMed ID: 32610677
[No Abstract] [Full Text] [Related]
13. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic significance of S100A4 overexpression in colorectal cancer: a meta-analysis.
Liu Y; Tang W; Wang J; Xie L; Li T; He Y; Qin X; Li S
Diagn Pathol; 2013 Nov; 8():181. PubMed ID: 24188373
[TBL] [Abstract][Full Text] [Related]
15. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated Expression Levels of Circular RNAs Serve as Prognostic and Clinicopathological Markers in Gastric Cancer: a Meta-Analysis.
Zhao G; Wu Y; Wu L; Huang J; Gan Y; Li H
Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865259
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance of HSP70 expression in gastric cancer: a systematic review and meta-analysis.
Wang X; Xie L; Zhu L
BMC Gastroenterol; 2021 Nov; 21(1):437. PubMed ID: 34809574
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and clinical significance of VEGFR-3 in gastric cancer: A meta-analysis.
Ge H; Yan Y; Guo L; He X; Yang X
Clin Chim Acta; 2017 Nov; 474():114-119. PubMed ID: 28939099
[TBL] [Abstract][Full Text] [Related]
19. Potential Role of Glucose Transporter-1 Expression in Gastric Cancer: A Meta-Analysis and Systematic Review.
Tao J; Zhang Y; Wang T
Iran J Public Health; 2020 Nov; 49(11):2044-2053. PubMed ID: 33708725
[TBL] [Abstract][Full Text] [Related]
20. HMGA1/HMGA2 protein expression and prognostic implications in gastric cancer.
Jun KH; Jung JH; Choi HJ; Shin EY; Chin HM
Int J Surg; 2015 Dec; 24(Pt A):39-44. PubMed ID: 26537313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
